Cargando…

Ischemic bowel disease in 2021

Ischemic bowel disease (ISBODI) includes colon ischemia, acute mesenteric ischemia (AMI) and chronic mesenteric ischemia (CMI). Epidemiologically, colon ischemia is the most common type followed by AMI and CMI. There are various risk factors for the development of ISBODI. Abdominal pain is the commo...

Descripción completa

Detalles Bibliográficos
Autor principal: Ahmed, Monjur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371501/
https://www.ncbi.nlm.nih.gov/pubmed/34447224
http://dx.doi.org/10.3748/wjg.v27.i29.4746
_version_ 1783739655796031488
author Ahmed, Monjur
author_facet Ahmed, Monjur
author_sort Ahmed, Monjur
collection PubMed
description Ischemic bowel disease (ISBODI) includes colon ischemia, acute mesenteric ischemia (AMI) and chronic mesenteric ischemia (CMI). Epidemiologically, colon ischemia is the most common type followed by AMI and CMI. There are various risk factors for the development of ISBODI. Abdominal pain is the common presenting symptom of each type. High clinical suspicion is essential in ordering appropriate tests. Imaging studies and colonoscopy with biopsy are the main diagnostic tests. Treatment varies from conservative measures to surgical resection and revascularization. Involvement of multidisciplinary team is essential in managing ISBODI. Although open surgery with revascularization plays an important role, recently there is an increasing interest in percutaneous endovascular treatment.
format Online
Article
Text
id pubmed-8371501
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-83715012021-08-25 Ischemic bowel disease in 2021 Ahmed, Monjur World J Gastroenterol Review Ischemic bowel disease (ISBODI) includes colon ischemia, acute mesenteric ischemia (AMI) and chronic mesenteric ischemia (CMI). Epidemiologically, colon ischemia is the most common type followed by AMI and CMI. There are various risk factors for the development of ISBODI. Abdominal pain is the common presenting symptom of each type. High clinical suspicion is essential in ordering appropriate tests. Imaging studies and colonoscopy with biopsy are the main diagnostic tests. Treatment varies from conservative measures to surgical resection and revascularization. Involvement of multidisciplinary team is essential in managing ISBODI. Although open surgery with revascularization plays an important role, recently there is an increasing interest in percutaneous endovascular treatment. Baishideng Publishing Group Inc 2021-08-07 2021-08-07 /pmc/articles/PMC8371501/ /pubmed/34447224 http://dx.doi.org/10.3748/wjg.v27.i29.4746 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Review
Ahmed, Monjur
Ischemic bowel disease in 2021
title Ischemic bowel disease in 2021
title_full Ischemic bowel disease in 2021
title_fullStr Ischemic bowel disease in 2021
title_full_unstemmed Ischemic bowel disease in 2021
title_short Ischemic bowel disease in 2021
title_sort ischemic bowel disease in 2021
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371501/
https://www.ncbi.nlm.nih.gov/pubmed/34447224
http://dx.doi.org/10.3748/wjg.v27.i29.4746
work_keys_str_mv AT ahmedmonjur ischemicboweldiseasein2021